Growth Metrics

Vanda Pharmaceuticals (VNDA) Operating Margin Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -40,178.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 530.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1,211.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 6,993.00
10 Vanda Pharmaceuticals 379.35 Mn 177.04 Mn 48.56 Mn -10,032.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -10,032.00
Dec 31, 2025 -8,081.00
Sep 30, 2025 -6,159.00
Jun 30, 2025 -7,859.00
Mar 31, 2025 -6,925.00
Dec 31, 2024 -3,202.00
Sep 30, 2024 -3,852.00
Jun 30, 2024 -3,832.00
Mar 31, 2024 -3,596.00
Dec 31, 2023 -3,112.00
Sep 30, 2023 -2,828.00
Jun 30, 2023 -2,097.00
Mar 31, 2023 342.00
Dec 31, 2022 332.00
Sep 30, 2022 -1,210.00
Jun 30, 2022 -1,138.00
Mar 31, 2022 -837.00
Dec 31, 2021 -455.00
Sep 30, 2021 275.00
Jun 30, 2021 995.00
Mar 31, 2021 1,090.00
Dec 31, 2020 2,030.00
Sep 30, 2020 2,475.00
Jun 30, 2020 1,932.00
Mar 31, 2020 2,092.00
Dec 31, 2019 867.00
Sep 30, 2019 1,978.00
Jun 30, 2019 3,005.00
Mar 31, 2019 3,313.00
Dec 31, 2018 6,401.00
Sep 30, 2018 4,635.00
Jun 30, 2018 2,805.00
Mar 31, 2018 5,207.00
Dec 31, 2017 -45,829.00
Sep 30, 2017 -211.00
Jun 30, 2017 19,434.00
Mar 31, 2017 26,956.00
Dec 31, 2016 8,700.00
Sep 30, 2016 6,066.00
Jun 30, 2016 2,773.00
Mar 31, 2016 1,908.00
Dec 31, 2015 3,440.00
Sep 30, 2015 3,143.00
Jun 30, 2015 7,671.00
Mar 31, 2015 5,569.00
Dec 31, 2014 52,402.00
Sep 30, 2014 3,153.00
Jun 30, 2014 -17,855.00
Mar 31, 2014 -29,079.00
Dec 31, 2013 -7,223.00
Sep 30, 2013 -7,261.00
Jun 30, 2013 -11,606.00